Still Hungry: The Mixed Meal Tolerance Test leaves something to be desired
As I have previously discussed, I am participating in the Protégé Encore study, which is an anti-CD3 monoclonal antibody clinical trial that is trying to prove the effectiveness of an investigational drug called teplizumab. We all know that type 1 … Read more